Unusual Uptake of Prostate Specific Tracer 68Ga-PSMA–HBED-CC in a Benign Thyroid Nodule
Authors:
- Nishikant Avinash DamleNDNishikant Avinash Damle
- Madhavi TripathiMTMadhavi Tripathi
- Partha Sarathi ChakrabortyPCPartha Sarathi Chakraborty
- Manas Kumar SahooMSManas Kumar Sahoo
- Chandrasekhar BalCBChandrasekhar Bal
- Shipra AggarwalShipra Aggarwal
- Geetanjali AroraGAGeetanjali Arora
- Praveen KumarPKPraveen Kumar
- Rajeev KumarRKRajeev Kumar
- Ravikant GuptaRGRavikant Gupta
- 22 March 2016
- journal article
- case report
- Published by Springer Nature in Nuclear Medicine and Molecular Imaging
- Vol. 50 (4) , 344-347
Abstract
68Ga-Prostate specific membrane antigen- N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid- positron emission tomography/computed tomography or 68 Ga- HBED-CC-PSMA PET/CT, popularly known as PSMA PET/CT, is able to detect a small volume of recurrent prostate carcinoma (PC) when there is a prostate specific antigen (PSA) rise on follow-up after prostatectomy or other definitive treatment for PC. The use of PSMA PET/CT in the initial staging in PC is uncertain at this time. Clinical studies are underway to define its exact role in the management of the disease. At the same time it is important to be aware of unexpected sites of uptake of this ligand. We present here the case of a 62-year-old male patient who underwent prostatectomy for adenocarcinoma prostate. He also had a long-standing left solitary thyroid nodule (STN). Four months after surgery, he had a rising trend in serum PSA levels on three occasions, but the absolute value was less than 4 at all times. He underwent a 68Ga-PSMA-HBED-CC PET/CT, but it did not reveal any recurrent/metastatic site of disease. However, there was increased tracer uptake in the left STN. Fine needle aspiration cytology revealed features of atypia of undetermined significance, Bethesda category III. The patient underwent a left hemithyroidectomy and the histopathology showed features of a follicular adenoma.Keywords
This publication has 13 references indexed in Scilit:
- Metastatic Poorly Differentiated Prostatic Carcinoma With Neuroendocrine DifferentiationClinical Nuclear Medicine, 2015
- Ga-68-PSMA-PET/CT bei ProstatakarzinomAktuelle Urologie, 2014
- [68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practiceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate CancerPharmaceuticals, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancerEJNMMI Research, 2012
- [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECHEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Imaging Prostate Cancer: An Update on Positron Emission Tomography and Magnetic Resonance ImagingCurrent Urology Reports, 2010
- The homodimer of prostate-specific membrane antigen is a functional target for cancer therapyProceedings of the National Academy of Sciences, 2003